Aimei Health Technology Co., Ltd. (AFJK): debt financing — Aimei Health extends business combination deadline to March 6, 2026; issues $34,331 promissory note

Aimei Health Technology Co., Ltd.

Deposited $34,330.96 into trust account to extend combination deadline by one month from Feb 6 to March 6, 2026 (fifteenth extension).
Issued unsecured promissory note to Aimei Health Ltd and United Hydrogen Group; funds equally divided ($17,165.48 each).
Note bears no interest; principal due upon business combination closing or convertible into private units at $10/unit.
Company still seeks initial business combination; trust funds remain reserved for public shareholders only.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Aimei Health Technology Co., Ltd. incurred loan of $34,330.96 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing due and payable upon the date on which the Company consummates a business combination.

Instrument: loan
Principal: $34,330.96
Counterparty: Aimei Health Ltd and United Hydrogen Group Inc.
Rate: does not bear interest
Maturity: due and payable upon the date on which the Company consummates a business combination
Event: incurrence

Exact text from the filing

the Company issued, on February 12, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands

View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Aimei Health Technology Co., Ltd. filing history →

Source: SEC EDGAR

accession 0001493152-26-006694

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.